Extracellular levels of glutamate are controlled with great precision both temporally and spatially, achieving efficient and selective synaptic excitation and preventing neuronal death by excitotoxicity. On one hand, glutamate concentrations in the synaptic cleft must rise rapidly to millimolar concentrations to ensure activation of postsynaptic ionotropic receptors. On the other hand, the average extracellular concentration of glutamate must be maintained at sub-micromolar levels to prevent cell death. These requirements are met by the explosive exocytotic release of glutamate and the high capacity and high affinity glutamate uptake system provided by the family of Na-dependent glutamate transporters. When transporter function is compromised experimentally or by metabolic crises such as ischemia, elevated tonic levels of glutamate and slowed clearance around synaptic release sites can result in seizures, enhanced spreading damage from ischemic insults and neuronal and organismal death. The objective of this proposal is to determine how much glutamate escapes from the synaptic cleft following release, how far from the release site glutamate reaches concentrations sufficient to activate receptors, how rapidly the uptake system sequesters glutamate, and how these processes are affected by physiological alterations in the amount of glutamate released including multivesicular release. We will use whole cell and outside-out patch clamp recordings in conjunction with two photon laser scanning microscopy and glutamate uncaging in acute slices of rat cerebellum and hippocampus to address the consequences of ionotropic and metabotropic glutamate receptor activation inside and outside of the synaptic cleft. Three dissimilar synapses will be studied to compare how their unique morphologies and expression patterns of receptors and transports affect the actions of glutamate following synaptic release.

Public Health Relevance

Understanding how the brain functions depends on knowledge of the fundamental unit of information processing within the brain called the synapse. To understand the synapse, we need detailed information about its physical structure, molecular constituents, biochemical and physiological mechanisms and how these properties change with age and experience. Rational design of therapies for neurological deficits is not possible without a fundamental understanding of synaptic function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56NS040056-10
Application #
8080109
Study Section
Neurotransporters, Receptors, and Calcium Signaling Study Section (NTRC)
Program Officer
Stewart, Randall R
Project Start
2000-05-18
Project End
2011-01-31
Budget Start
2010-07-15
Budget End
2011-01-31
Support Year
10
Fiscal Year
2010
Total Cost
$385,000
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Nahir, Ben; Jahr, Craig E (2013) Activation of extrasynaptic NMDARs at individual parallel fiber-molecular layer interneuron synapses in cerebellum. J Neurosci 33:16323-33
Herman, Melissa A; Nahir, Ben; Jahr, Craig E (2011) Distribution of extracellular glutamate in the neuropil of hippocampus. PLoS One 6:e26501
Christie, Jason M; Jahr, Craig E (2009) Selective expression of ligand-gated ion channels in L5 pyramidal cell axons. J Neurosci 29:11441-50